[1A5-1A5];[1B12-1B12];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
1A5;1B12
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(1)BSC530 stage 11 embryos show a reduction in neuroblast numbers.
The presence of P+PBac{XP5.WH5}BSC530 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC530 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}f03741 and P{XP}CG13369d06819 insertion sites are 1A5;1B12.